Intriguingly, strong expression of syndecan-1 can also confer aggressive behavior to some tumor types as reported in dedifferentiated thyroid [49], poorly differentiated prostate [50,51], high grade breast [52,53], high grade ovarian [54,55], and high grade hepatocellular carcinomas [12]. Here, SDC1 is linked to hepatocellular carcinoma.